Literature DB >> 29273895

Smear Campaign: Misattribution of Pancytopenia to a Tick-Borne Illness.

Jessica Lee1,2, Soraya Azzawi1, Michael J Peluso1,2, Aaron Richterman1,2, Haiyan Ramirez Batlle1,2, Maria A Yialamas3,4,5.   

Abstract

We report the case of a 51-year-old woman presenting with a targetoid rash and pancytopenia after a tick bite. Initial evaluation was notable for severe neutropenia on the complete blood cell count differential, a positive Lyme IgM antibody, and a peripheral blood smear demonstrating atypical lymphocytes. While her pancytopenia was initially attributed to tick-borne illness, peripheral flow cytometry showed 7% myeloblasts, and a bone marrow biopsy confirmed 60% blasts. The patient was ultimately diagnosed with acute myelogenous leukemia, in addition to early, localized Lyme disease. This case highlights the differential diagnosis for pancytopenia, cytopenia patterns for different tick-borne illnesses, the risk of premature closure in internal medicine, and management of Lyme disease in hosts with altered immunity.

Entities:  

Keywords:  Lyme disease; acute myelogenous leukemia; pancytopenia; tick-borne illness

Mesh:

Substances:

Year:  2017        PMID: 29273895      PMCID: PMC5880759          DOI: 10.1007/s11606-017-4241-5

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  12 in total

1.  Avoiding premature closure in sequential diagnosis.

Authors:  D McSherry
Journal:  Artif Intell Med       Date:  1997-07       Impact factor: 5.326

Review 2.  The differential diagnosis and bone marrow evaluation of new-onset pancytopenia.

Authors:  Elizabeth P Weinzierl; Daniel A Arber
Journal:  Am J Clin Pathol       Date:  2013-01       Impact factor: 2.493

3.  Neutropenia in Congenital and Adult Babesiosis.

Authors:  Gary P Wormser; Patrick Villafuerte; Sheila M Nolan; Guiqing Wang; Robert G Lerner; Kirsten L Saetre; Mazen H Maria; John A Branda
Journal:  Am J Clin Pathol       Date:  2015-07       Impact factor: 2.493

4.  The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.

Authors:  B Fürst; M Glatz; H Kerl; R R Müllegger
Journal:  Clin Exp Dermatol       Date:  2006-07       Impact factor: 3.470

5.  U.S. public's experience with ticks and tick-borne diseases: Results from national HealthStyles surveys.

Authors:  Sarah A Hook; Christina A Nelson; Paul S Mead
Journal:  Ticks Tick Borne Dis       Date:  2015-04-15       Impact factor: 3.744

6.  The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.

Authors:  R B Nadelman; J Nowakowski; G Forseter; N S Goldberg; S Bittker; D Cooper; M Aguero-Rosenfeld; G P Wormser
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

Review 7.  Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment.

Authors:  J Stephen Dumler; John E Madigan; Nicola Pusterla; Johan S Bakken
Journal:  Clin Infect Dis       Date:  2007-07-15       Impact factor: 9.079

8.  Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Authors:  Gary P Wormser; Maria E Aguero-Rosenfeld; Mary E Cox; John Nowakowski; Robert B Nadelman; Diane Holmgren; Donna McKenna; Susan Bittker; Lois Zentmaier; Denise Cooper; Dionysios Liveris; Ira Schwartz; Harold W Horowitz
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

9.  Course and outcome of Early Lyme borreliosis in patients with hematological malignancies.

Authors:  Vera Maraspin; Eva Ružić-Sabljić; Lara Lusa; Franc Strle
Journal:  Clin Infect Dis       Date:  2015-05-08       Impact factor: 9.079

10.  An etiological reappraisal of pancytopenia - largest series reported to date from a single tertiary care teaching hospital.

Authors:  Arvind Jain; Manjiri Naniwadekar
Journal:  BMC Hematol       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.